Literature DB >> 16721495

A toddler with recurrent oral and genital ulcers.

Zehre Yüksel1, Joachim J Schweizer, Petronella E C Mourad-Baars, Ram N Sukhai, Luisa M Mearin.   

Abstract

In western countries, when a child presents with recurrent oral ulcers and colitis, the diagnosis of Crohn's disease is mostly made. In our patient, the diagnosis was Behçet's disease with gastrointestinal manifestations. Behçet's disease with gastrointestinal manifestations has a similar clinical presentation to Crohn's disease, but there is more organ involvement and the prognosis is more severe in the former. Because there is limited experience in the treatment of Behçet's disease in the paediatric population, successful and unsuccessful treatment modalities in both paediatric and adult populations should be reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16721495     DOI: 10.1007/s10067-006-0212-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  5 in total

Review 1.  Pulmonary complications of Behçet's disease.

Authors:  Feyza Erkan; Esen Kiyan; Atadan Tunaci
Journal:  Clin Chest Med       Date:  2002-06       Impact factor: 2.878

2.  Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behçet's disease.

Authors:  A E Yücel; H Kart-Köseoglu; Y A Akova; B Demirhan; S Boyacioglu
Journal:  Rheumatology (Oxford)       Date:  2004-03       Impact factor: 7.580

Review 3.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

4.  Crohn's disease with Behçet's syndrome like appearance: a case report.

Authors:  B Kallinowski; G Nöldge; A Stiehl
Journal:  Z Gastroenterol       Date:  1994-11       Impact factor: 2.000

5.  Childhood Behçet's disease: clinical features and comparison with adult-onset disease.

Authors:  I Krause; Y Uziel; D Guedj; M Mukamel; L Harel; Y Molad; A Weinberger
Journal:  Rheumatology (Oxford)       Date:  1999-05       Impact factor: 7.580

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.